Date Field | Doc. No. | Description (Pages) |
---|
Jun 12, 2019 | 67 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [66] filed by Appellants iCeutica Pty Ltd and Egalet U.S., Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [613354] [JAB] [Entered: 06/12/2019 08:50 AM] (2) |
Jun 10, 2019 | 66 | MOTION of Appellants Egalet U.S., Inc. and iCeutica Pty Ltd to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 06/10/2019 by email. [612608] [18-1658] [Oliver Richards] [Entered: 06/10/2019 07:14 AM] (7) |
Jun 7, 2019 | 65 | Submitted after ORAL ARGUMENT by Oliver Richards for iCeutica Pty Ltd and Egalet U.S., Inc. and William R. Zimmerman for Lupin Pharmaceuticals, Inc. and Lupin Limited. Panel: Judge: Prost , Judge: Lourie , Judge: Hughes. [612346] [JAB] [Entered: 06/07/2019 12:12 PM] (0) |
Jun 4, 2019 | 64 | Response to notice of oral argument from the Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. [611318] [18-1658] [Oliver Richards] [Entered: 06/04/2019 12:35 PM] (3) |
May 23, 2019 | 63 | Certificate of Interest for the Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. Service: 05/23/2019 by email. [609354] [18-1658] [Oliver Richards] [Entered: 05/23/2019 02:02 PM] (3) |
May 22, 2019 | 62 | Entry of appearance for John A. Dragseth as of counsel for Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. Service: 05/22/2019 by email. [609135] [18-1658] [John Dragseth] [Entered: 05/22/2019 04:29 PM] (2) |
May 22, 2019 | 61 | Entry of appearance for William Chad Shear as of counsel for Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. Service: 05/22/2019 by email. [609126] [18-1658] [W. Shear] [Entered: 05/22/2019 04:14 PM] (2) |
May 22, 2019 | 60 | Entry of appearance for Craig Countryman as principal counsel for Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. Service: 05/22/2019 by email. [609123] [18-1658] [Craig Countryman] [Entered: 05/22/2019 04:11 PM] (2) |
May 22, 2019 | 59 | Entry of appearance for Megan A. Chacon as of counsel for Appellants iCeutica Pty Ltd and Egalet U.S., Inc.. Service: 05/22/2019 by email. [609122] [18-1658] [Megan Chacon] [Entered: 05/22/2019 04:11 PM] (2) |
May 22, 2019 | 58 | Entry of appearance for Oliver J. Richards as of counsel for Appellants Egalet U.S., Inc. and iCeutica Pty Ltd. Service: 05/22/2019 by email. [609117] [18-1658] [Oliver Richards] [Entered: 05/22/2019 04:06 PM] (2) |
May 22, 2019 | 57 | ORDER filed granting motion to substitute party [56] filed by Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Appellant Iroko Pharmaceuticals, LLC substituted by Appellant Egalet U.S., Inc. in 18-1658. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [608890] [JAB] [Entered: 05/22/2019 09:15 AM] (2) |
May 9, 2019 | 56 | MOTION of Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd to substitute party [Consent: unopposed]. Service: 05/09/2019 by email. [606431] [18-1658]--[Edited 05/22/2019 by JAB to correct filers] [Oliver Richards] [Entered: 05/09/2019 07:48 PM] (7) |
Apr 24, 2019 | 55 | Response to notice of oral argument from the Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. [602789] [18-1658] [John Dragseth] [Entered: 04/24/2019 07:34 PM] (3) |
Apr 23, 2019 | 54 | Entry of appearance for John A. Dragseth as of counsel for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 04/23/2019 by email. [602399] [18-1658] [Craig Countryman] [Entered: 04/23/2019 06:39 PM] (2) |
Apr 23, 2019 | 53 | Response to notice of oral argument from the Appellees Lupin Limited and Lupin Pharmaceuticals, Inc.. [602217] [18-1658] [William Zimmerman] [Entered: 04/23/2019 12:04 PM] (3) |
Apr 22, 2019 | 52 | NOTICE OF ORAL ARGUMENT. Panel: 1906L. Case scheduled Jun 07, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 05/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [601966] [JAB] [Entered: 04/22/2019 01:43 PM] (2) |
Jan 30, 2019 | 51 | 6 paper copies of the Confidential Joint Appendix in 2 Volumes [46] received from Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. [582069] [JCP] [Entered: 01/30/2019 12:42 PM] (0) |
Jan 30, 2019 | 50 | 6 paper copies of the Confidential Reply Brief [42] received from Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. [582064] [JCP] [Entered: 01/30/2019 12:39 PM] (0) |
Jan 23, 2019 | 49 | Notice from Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 01/23/2019 by email. [580317] [18-1658] [William Zimmerman] [Entered: 01/23/2019 04:37 PM] (3) |
Jan 23, 2019 | 48 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [580090] [SJ] [Entered: 01/23/2019 10:54 AM] (1) |
Jan 23, 2019 | 47 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [580089] [SJ] [Entered: 01/23/2019 10:53 AM] (0) |
Jan 11, 2019 | 46 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED (2 vols.) for Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. Number of Pages: 889. Service: 01/11/2019 by email. [577827]--[compliance review complete - Edited 01/23/2019 by SMJ] [Oliver Richards] [Entered: 01/11/2019 11:39 PM] (0) |
Jan 11, 2019 | 45 | MODIFIED ENTRY: APPENDIX FILED (2 vols.) for Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. Number of Pages: 889. Service: 01/11/2019 by email. [577826] --[compliance review complete - Edited 01/23/2019 by SMJ] [Oliver Richards] [Entered: 01/11/2019 11:33 PM] (893) |
Jan 11, 2019 | 44 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 01/11/2019 by email. [577824] [18-1658] [Oliver Richards] [Entered: 01/11/2019 10:57 PM] (6) |
Jan 4, 2019 | 43 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. Number of Pages: 24. Service: 01/04/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [576099] --[compliance review complete - Edited 01/10/2019 by SMJ] [Oliver Richards] [Entered: 01/04/2019 08:55 PM] (32) |
Jan 4, 2019 | 42 | MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. Number of Pages: 24. Service: 01/04/2019 by email. [576098]--[compliance review complete - Edited 01/10/2019 by SMJ] [Oliver Richards] [Entered: 01/04/2019 08:37 PM] (0) |
Oct 30, 2018 | 41 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [39] filed by Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Reply brief is due 01/04/2019. No further extensions should be anticipated. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [561436] [SJ] [Entered: 10/30/2018 03:54 PM] (0) |
Oct 30, 2018 | 40 | 6 paper copies of the Confidential Opening Response Brief [37] received from Appellees Lupin Limited and Lupin Pharmaceuticals, Inc.. [561383] [CJF] [Entered: 10/30/2018 02:47 PM] (0) |
Oct 29, 2018 | 39 | MOTION of Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC to extend the time to 01/04/2019 to file the Reply Brief. [Consent: unopposed]. Service: 10/29/2018 by email. [561058] [18-1658] [Craig Countryman] [Entered: 10/29/2018 04:23 PM] (9) |
Oct 25, 2018 | 38 | BRIEF FILED for Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. [36]. Number of Pages: 54. Service: 10/22/2018 by email. Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd reply brief is due 11/05/2018. [560349] [SJ] [Entered: 10/25/2018 11:25 AM] (66) |
Oct 22, 2018 | 37 | CONFIDENTIAL BRIEF FILED for Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. [35]. Number of Pages: 54. Service: 10/22/2018 by email. The paper copies of the brief should be received by the court on or before 11/01/2018. [560348] [SJ] [Entered: 10/25/2018 11:21 AM] (0) |
Oct 22, 2018 | 36 | TENDERED from Appellees Lupin Limited and Lupin Pharmaceuticals, Inc.. Title: RESPONSE BRIEF. Service: 10/22/2018 by email. [559314] [18-1658] [William Zimmerman] [Entered: 10/22/2018 05:54 PM] (66) |
Oct 22, 2018 | 35 | TENDERED from Appellees Lupin Limited and Lupin Pharmaceuticals, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 10/22/2018 by email. [559313] [18-1658] [William Zimmerman] [Entered: 10/22/2018 05:51 PM] (0) |
Aug 10, 2018 | 34 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file brief Docket No. [32], ERROR: COI is incomplete. CORRECTION: for all future filings in which a COI is required, all 5 questions on the current version of the form must be answered. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [541994] [SJ] [Entered: 08/10/2018 09:46 AM] (0) |
Aug 10, 2018 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file response brief [32] filed by Appellees Lupin Pharmaceuticals, Inc. and Lupin Limited. Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. brief due 10/22/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [541992] [SJ] [Entered: 08/10/2018 09:44 AM] (0) |
Aug 8, 2018 | 32 | MOTION of Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. to extend the time to 10/22/2018 to file the August 21, 2018 Opposition Brief. [Consent: unopposed]. Service: 08/08/2018 by email. [541603] [18-1658] [William Zimmerman] [Entered: 08/08/2018 05:01 PM] (7) |
Jul 30, 2018 | 31 | 6 paper copies of the Corrected Confidential Opening Brief [29] received from Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd. [539299] [CJF] [Entered: 07/30/2018 09:55 AM] (0) |
Jul 20, 2018 | 30 | CORRECTED BRIEF FILED for Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd [28]. Number of Pages: 54. Service: 07/20/2018 by email. [537715] [SJ] [Entered: 07/23/2018 01:16 PM] (133) |
Jul 20, 2018 | 29 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd [27]. Number of Pages: 54. Service: 07/20/2018 by email. The paper copies of the brief should be received by the court on or before 07/30/2018. [537712] [SJ] [Entered: 07/23/2018 01:11 PM] (0) |
Jul 20, 2018 | 28 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: CORRECTED OPENING BRIEF. Service: 07/20/2018 by email. [537505] [18-1658] [Oliver Richards] [Entered: 07/20/2018 04:58 PM] (133) |
Jul 20, 2018 | 27 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 07/20/2018 by email. [537497] [18-1658] [Oliver Richards] [Entered: 07/20/2018 04:53 PM] (0) |
Jul 20, 2018 | 26 | Notice of Correction to the Brief Doc No. [25], confidential Brief Doc No. [24] for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 07/20/2018 by email. [537492] [18-1658] [Oliver Richards] [Entered: 07/20/2018 04:50 PM] (3) |
Jul 13, 2018 | 25 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: CORRECTED OPENING BRIEF. Service: 07/13/2018 by email. [535930] [18-1658] This brief has been corrected. See Doc. No. [30] [Oliver Richards] [Entered: 07/13/2018 05:54 PM] (0) |
Jul 13, 2018 | 24 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 07/13/2018 by email. [535928] [18-1658] This brief has been corrected. See Doc. No. [29] [Oliver Richards] [Entered: 07/13/2018 05:49 PM] (0) |
Jul 12, 2018 | 23 | NOTICE OF REJECTION: The brief of Appellants Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd, Opening Brief [20] [19], is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 07/26/2018. Appellees Lupin Limited and Lupin Pharmaceuticals, Inc. brief is due 08/21/2018. Service as of this date by the Clerk of Court. [535313] [SJ] [Entered: 07/12/2018 08:58 AM] (2) |
Jul 10, 2018 | 22 | Official caption revised to reflect dismissal of cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [534841] [SJ] [Entered: 07/10/2018 01:05 PM] (0) |
Jul 10, 2018 | 21 | ORDER granting motion to terminate appeal [15] filed by Cross-Appellants Lupin Pharmaceuticals, Inc. and Lupin Limited (18-1661); issuing mandate (18-1661). Service as of this date by the Clerk of Court. [534831] [18-1658, 18-1661] [SJ] [Entered: 07/10/2018 12:58 PM] (2) |
Jul 9, 2018 | 20 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: OPENING BRIEF. Service: 07/09/2018 by email. [534657] [18-1658] This brief has been rejected. See Doc. No. [23] [Oliver Richards] [Entered: 07/09/2018 08:20 PM] (0) |
Jul 9, 2018 | 19 | TENDERED from Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Title: CONFIDENTIAL OPENING BRIEF Service: 07/09/2018 by email. [534656] [18-1658] This brief has been rejected. See Doc. No. [23] [Oliver Richards] [Entered: 07/09/2018 08:09 PM] (0) |
Jul 9, 2018 | 18 | Entry of appearance for Megan A. Chacon as of counsel for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 07/09/2018 by email. [534638] [18-1658] [Oliver Richards] [Entered: 07/09/2018 06:46 PM] (2) |
Jul 9, 2018 | 17 | Entry of appearance for W. Chad Shear as of counsel for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 07/09/2018 by email. [534637] [18-1658] [Oliver Richards] [Entered: 07/09/2018 06:44 PM] (2) |
Jul 9, 2018 | 16 | Entry of appearance for Oliver J. Richards as of counsel for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 07/09/2018 by email. [534636] [18-1658] [Oliver Richards] [Entered: 07/09/2018 06:43 PM] (2) |
Jul 9, 2018 | 15 | MOTION of Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc. to terminate appeal through dismissal of cross/consolidated appeal. Cases to be terminated: 18-1661 [Consent: unopposed]. Service: 07/09/2018 by email. [534573] [18-1658] [William Zimmerman] [Entered: 07/09/2018 04:38 PM] (5) |
Apr 19, 2018 | 14 | **TEXT ONLY** ORDER granting motion to extend time to file brief [13] filed by Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Brief due 07/09/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [515241] [CFT] [Entered: 04/19/2018 12:08 PM] (0) |
Apr 18, 2018 | 13 | MOTION of Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC to extend the time to 07/09/2018 to file the Appellants' Opening Brief. [Consent: unopposed]. Service: 04/18/2018 by email. [515065] [18-1658] [Craig Countryman] [Entered: 04/18/2018 07:27 PM] (9) |
Mar 23, 2018 | 12 | Docketing Statement for the Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 03/23/2018 by email. [507705] [18-1658] [Craig Countryman] [Entered: 03/23/2018 06:27 PM] (3) |
Mar 23, 2018 | 11 | Certificate of Interest for the Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 03/23/2018 by email. [507704] [18-1658] [Craig Countryman] [Entered: 03/23/2018 06:25 PM] (3) |
Mar 23, 2018 | 10 | Entry of appearance for Craig E. Countryman as principal counsel for Appellants iCeutica Pty Ltd and Iroko Pharmaceuticals, LLC. Service: 03/23/2018 by email. [507703] [18-1658] [Craig Countryman] [Entered: 03/23/2018 06:23 PM] (2) |
Mar 21, 2018 | 9 | Entry of appearance for Jeremiah S. Helm as of counsel for Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506987] [18-1658] [Jeremiah Helm] [Entered: 03/21/2018 06:32 PM] (2) |
Mar 21, 2018 | 8 | Entry of appearance for Karen M. Cassidy as of counsel for Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506986] [18-1658] [Karen Cassidy] [Entered: 03/21/2018 06:29 PM] (2) |
Mar 21, 2018 | 7 | Entry of appearance for Jonathan E. Bachand as of counsel for Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506985] [18-1658] [Jonathan Bachand] [Entered: 03/21/2018 06:26 PM] (2) |
Mar 21, 2018 | 6 | Entry of appearance for Carol Pitzel Cruz as of counsel for Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506984] [18-1658] [Carol Pitzel Cruz] [Entered: 03/21/2018 06:23 PM] (2) |
Mar 21, 2018 | 5 | Docketing Statement for the Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506981] [18-1658] [William Zimmerman] [Entered: 03/21/2018 06:18 PM] (4) |
Mar 21, 2018 | 4 | Certificate of Interest for the Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506980] [18-1658] [William Zimmerman] [Entered: 03/21/2018 06:15 PM] (4) |
Mar 21, 2018 | 3 | Entry of appearance for William R. Zimmerman as principal counsel for Cross-Appellants Lupin Limited and Lupin Pharmaceuticals, Inc.. Service: 03/21/2018 by email. [506978] [18-1658] [William Zimmerman] [Entered: 03/21/2018 06:13 PM] (2) |
Mar 9, 2018 | 2 | Note to file: The following cases are associated:18-1658 (lead) with 18-1661 (cross-appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [503861] [18-1658, 18-1661] [SJ] [Entered: 03/09/2018 02:32 PM] (0) |
Mar 9, 2018 | 1 | Appeal docketed. Received: 03/05/2018. [503833]Entry of Appearance due 03/23/2018. Certificate of Interest is due on 03/23/2018. Docketing Statement due 03/23/2018. Appellant/Petitioner's brief is due 05/08/2018. [SJ] [Entered: 03/09/2018 01:49 PM] (51) |